Ligand Pharmaceuticals Inc (NASDAQ:LGND)

73.54
Delayed Data
As of Mar 31
 +2.14 / +3.00%
Today’s Change
45.25
Today|||52-Week Range
83.95
+10.09%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Higgins John L
Chief Executive Officer
Sale11/17/202210,000$78.32$783.2K-6.11%
Higgins John L
Director
Sale12/16/202210,000$61.87$618.7K+17.41%
Higgins John L
Director
Sale12/28/20225,289$66.29$350.6K+10.97%
Higgins John L
Chief Executive Officer
Sale9/16/20223,000$89.35$268.1K-16.27%
Korenberg Matthew Edward
President & Chief Operating Officer
Sale12/28/20223,859$66.29$255.8K+10.97%
Higgins John L
Director
Buy12/12/202220,000$12.78$255.6K+13.52%
Higgins John L
Director
Sale12/12/20223,944$64.80$255.6K+13.52%
Korenberg Matthew Edward
President & Chief Operating Officer
Sale2/15/20232,890$72.98$210.9K+0.79%
Foehr Matthew William
President & Chief Operating Officer
Buy5/13/20222,500$82.76$206.9K-14.43%
Higgins John L
Chief Executive Officer
Sale9/15/20222,000$90.00$180.0K-18.38%
Page of 4